Chromosome 1q21 gain is an adverse prognostic factor for newly diagnosed multiple myeloma patients treated with bortezomib-based regimens
Xiao Liu(Central South University), Guangxun Gao(Xijing Hospital), Zhengcong Cao(Air Force Medical University), Biao Tian(Xijing Hospital), Weijing Jia(Xijing Hospital), Juan Feng(Peking University), Shuangshuang Jia(Xijing Hospital), Xiaoli Xin(Xijing Hospital), Yaya Gao(Xijing Hospital), Yuping Chu(Xijing Hospital), Hailong Tang(Xijing Hospital), Chunyan Zhang(Shanxi Medical University), Na Zhang(Shanghai Institute of Organic Chemistry), Hongjuan Dong(Xijing Hospital), Ziwei Chang(ShanghaiTech University), Yanhua Zheng(Xijing Hospital), Xiangxiang Liu(Nanjing Medical University), Ruifeng Yuan(Xijing Hospital)
Cited by 10
Related Papers
RIP3, an Energy Metabolism Regulator That Switches TNF-Induced Cell Death from Apoptosis to Necrosis
|Science|2009|1.9k
RETRACTED ARTICLE: CircHIPK3 promotes colorectal cancer growth and metastasis by sponging miR-7
|Cell Death and Disease|2018|715
Single-cell analysis reveals transcriptomic remodellings in distinct cell types that contribute to human prostate cancer progression
|Nature Cell Biology|2021|537
Induction of tumor angiogenesis by Slit-Robo signaling and inhibition of cancer growth by blocking Robo activity
|Cancer Cell|2003|396
A <i>Francisella tularensis</i> Pathogenicity Island Required for Intramacrophage Growth
|Journal of Bacteriology|2004|365